ArticleInternal medicine journal2025

Is semaglutide cost-effective at closing the gap for Aboriginal and Torres Strait Islander Australians with cardiovascular disease and obesity without type 2 diabetes?

Satyen Hargovan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.